Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
For instance, the 2022 ESPEN Guidelines recommended a daily supplementation of 1,500 to 5,000 International Units (IU) for patients at risk of vitamin D deficiency or who repeatedly experience vitamin D deficiency; however, guidelines from Italy suggested a daily supplement dose of 800 to 1,000 IU for patients with vitamin D deficiency.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Dose: response effects of vitamin D supplementation on vitamin D status, glycosylated hemoglobin and total cholesterol in patients with diabetes mellitus: a systematic review and meta-analysis
Source: Article title.
Dose: response effects of vitamin D supplementation on vitamin D status, glycosylated hemoglobin and total cholesterol in patients with diabetes mellitus: a systematic review and meta-analysis
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Dose-response effects of vitamin D supplementation on vitamin D status, glycosylated hemoglobin and total cholesterol in patients with diabetes mellitus: a systematic review and meta-analysis
Systematic review · Frontiers in Nutrition · 2025
Original publication title
Dose: response effects of vitamin D supplementation on vitamin D status, glycosylated hemoglobin and total cholesterol in patients with diabetes mellitus: a systematic review and meta-analysis
Copyright © 2025 Cao, Zhou, Zhang, Zhang and Zhao.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
The impact of vitamin D levels on glycemic control and lipid metabolism in diabetic patients has received widespread attention. However, currently, there was no unified standard for vitamin D supplementation dosages, with significant variations among guideline recommendations. For instance, the 2022 ESPEN Guidelines recommended a daily supplementation of 1,500 to 5,000 International Units (IU) for patients at risk of vitamin D deficiency or who repeatedly experience vitamin D deficiency; however, guidelines from Italy suggested a daily supplement dose of 800 to 1,000 IU for patients with vitamin D deficiency.
In this study, we searched the PubMed, Web of Science, Embase, Cochrane Library, CBM, CNKI, and Wanfang databases from their inception to 31 May 2024 for literature. The effects of different supplementation levels on vitamin D levels, glycosylated hemoglobin (HbA1c) levels and total cholesterol (TC) levels were analyzed using random-effects and fixed-effects models, respectively, and we applied the Modified Jadad Scale and the Newcastle-Ottawa Scale (NOS) score to evaluate the quality of the RCT studies and retrospective analyses, respectively. We included a total of seven papers involving 468 patients with a follow-up period of 3 to 6 months.
The results of the study showed that vitamin D levels were significantly higher in the high-dose group than in the low-dose group at both 3 and 6 months of treatment [mean difference (MD) = −12.48, 95% confidence interval (CI): −15.25 to −9.72 and MD = −28.22, 95% CI (−40.92, −15.72), both p < 0.05], and the effect of prolonged treatment was more significant. HbA1c levels were significantly lower in the high-dose group than in the low-dose group [MD = 0.41, 95% CI (0.14, 0.67), p = 0.003], and TC levels were not significantly different between the two groups [MD = 1.84, 95% CI (−8.07, 0.67), p = 0.72].
Therefore, in patients with diabetes mellitus complicated by vitamin D deficiency, higher-dose supplementation (>4,000 IU/day) might have had potential advantages in increasing vitamin D levels and improving glycemic control. However, further studies were still needed to clarify the long-term safety and risk: benefit ratio of higher-dose supplementation.
Authors’ abstract
The impact of vitamin D levels on glycemic control and lipid metabolism in diabetic patients has received widespread attention. However, currently, there was no unified standard for vitamin D supplementation dosages, with significant variations among guideline recommendations. For instance, the 2022 ESPEN Guidelines recommended a daily supplementation of 1,500 to 5,000 International Units (IU) for patients at risk of vitamin D deficiency or who repeatedly experience vitamin D deficiency; however, guidelines from Italy suggested a daily supplement dose of 800 to 1,000 IU for patients with vitamin D deficiency.
In this study, we searched the PubMed, Web of Science, Embase, Cochrane Library, CBM, CNKI, and Wanfang databases from their inception to 31 May 2024 for literature. The effects of different supplementation levels on vitamin D levels, glycosylated hemoglobin (HbA1c) levels and total cholesterol (TC) levels were analyzed using random-effects and fixed-effects models, respectively, and we applied the Modified Jadad Scale and the Newcastle-Ottawa Scale (NOS) score to evaluate the quality of the RCT studies and retrospective analyses, respectively. We included a total of seven papers involving 468 patients with a follow-up period of 3 to 6 months.
The results of the study showed that vitamin D levels were significantly higher in the high-dose group than in the low-dose group at both 3 and 6 months of treatment [mean difference (MD) = −12.48, 95% confidence interval (CI): −15.25 to −9.72 and MD = −28.22, 95% CI (−40.92, −15.72), both p < 0.05], and the effect of prolonged treatment was more significant. HbA1c levels were significantly lower in the high-dose group than in the low-dose group [MD = 0.41, 95% CI (0.14, 0.67), p = 0.003], and TC levels were not significantly different between the two groups [MD = 1.84, 95% CI (−8.07, 0.67), p = 0.72].
Therefore, in patients with diabetes mellitus complicated by vitamin D deficiency, higher-dose supplementation (>4,000 IU/day) might have had potential advantages in increasing vitamin D levels and improving glycemic control. However, further studies were still needed to clarify the long-term safety and risk: benefit ratio of higher-dose supplementation.
Publication and source details
Original title: Dose: response effects of vitamin D supplementation on vitamin D status, glycosylated hemoglobin and total cholesterol in patients with diabetes mellitus: a systematic review and meta-analysis
Lu Cao; Nan Zhou; Dan Zhang; Peng Zhang; Ying Zhao
Frontiers in Nutrition · 2025
* Correspondence: Ying Zhao, zhaoyingsrm@163.comCopyright © 2025 Cao, Zhou, Zhang, Zhang and Zhao.2025Cao, Zhou, Zhang, Zhang and Zhaohttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by grants from the Shaanxi Provincial People’s Hospital Science and Technology Development Incubation Fund Project (No. 2023YJY-73) and Key Research and Development Program of Shaanxi Provincial Department of Science and Technology (No. 2025SF-YBXM-054).Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:51:16.110698+00:00
DOI: 10.3389/fnut.2025.1663019 · PMC12635534